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Abstract  
This Guideline refers to infants, children and adolescents aged 0-18 years. The areas covered include: 
indications for diagnostic and therapeutic esophagogastroduodenoscopy and ileo-colonoscopy; endoscopy 
for foreign body ingestion; corrosive ingestion and stricture/stenosis endoscopic management; upper and 
lower gastrointestinal bleeding; endoscopic retrograde cholangio-pancreatography and endoscopic 
ultrasonography. Percutaneous endoscopic gastrostomy and endoscopy specific to inflammatory bowel 
disease (IBD) has been dealt with in other Guidelines [1-3] and are therefore not mentioned in this 
Guideline. Training and ongoing skill maintenance are to be dealt with in an imminent sister publication to 
this. 
Keywords: pediatric; esophagogastroduodenoscoy; ileo-colonoscopy; Colonoscopy; 
polypectomy; strictures; stents; fully-covered self-expandable metal stents; mitomycin C; balloon dilation; 
bougie dilation; polyps; snares; electrocautery; ERCP; endo-ultrasound; EUS; caustic ingestion; foreign 
body; Roth net; button battery; battery; magnets; acute upper gastrointestinal bleeding; esophageal atresia; 
graft versus host disease; inflammatory bowel disease; polyethylene glycol; triamcinolone acetonide; 
dexamethasone; video capsule endoscopy; varices; peptic ulcer disease; esophagitis; gastroesophageal 
reflux; bowel preparation; ulcerative colitis; Crohn's disease; mucosal biopsy; Carbon Dioxide; octreotide; 
food bolus impaction; drug packet ingestion; Magill forceps; rigid esophagoscopy; glucagon; 
Barrett's; Hematemesis; Melena; balloon enterosopy; Diuelafoy's; Portal hypertension; terminal ileal 
intubation; sclerotherapy; gastric varix glue injection; cholestatic jaundice; gall stones; pancreatitis; 
pancreatic pseudocysts; anemia; dysphagia; odynophagia; eosinophilic esophagitis. 
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Time definitions used: 
Emergent/emergency: <2 hours. 
Urgent/urgently:  <12 hours or <24 hours and defined in text. 
Early: <48 hours but may be at clinician‟s discretion. 
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Introduction 
Gastrointestinal (GI) endoscopy in the pediatric population has evolved during the last thirty years with an 
increasing number of diagnostic and therapeutic applications. Technological improvements in endoscope 
design and endoscopic devices have contributed to the evolution of pediatric endoscopy. 
Endoscopy in the pediatric population has generally, to date, been performed by both non-pediatric 
endoscopists and pediatric endoscopists. 
The aim of this evidence-based and consensus-based Guideline, commissioned by the European Society for 
Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) and the European Society of 
Gastrointestinal Endoscopy (ESGE) is to provide a comprehensive review of the clinical indications and 
timing of diagnostic and therapeutic endoscopy in pediatric patients. It is not meant to be a comprehensive 
overview of a patient‟s care and investigation/therapy for each area will, of course, involve the clinician‟s 
discretion in terms of the place of endoscopy in overall management, encompassing, as it must, 
complementary non-endoscopic approaches. The role of endoscopy in the overall management will depend 
on a number of factors including but not limited to the specific clinical features, the 
availability/appropriateness of non-endoscopic approaches, and the available skills of the endoscopist. This 
Guideline tries to address this issue of endoscopist skills, and certainly the upcoming ESPGHAN/ESGE 
Guideline on training in pediatric endoscopy will help in this respect. How, where and when endoscopy 
may be employed in pediatric management is particularly important in the areas of GI bleeding and 
ERCP/EUS.  
This undertaking is the first joint endoscopy review between pediatric and adult endoscopy representative 
groups in Europe. Our aspiration is that the Guideline may lead to a degree of standardization in the utility 
and practice of endoscopic approaches for children, thereby contributing to excellence and appropriateness 
of care.  
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Percutaneous endoscopic gastrostomy and endoscopy specific to inflammatory bowel disease (IBD) have 
been dealt with in other Guidelines [2–4], and are therefore not mentioned in the pediatric GI endoscopy 
[1] Guideline. Training and ongoing skill maintenance will be addressed in an imminent sister publication. 
 
Methods 
ESPGHAN  and ESGE agreed to develop a joint Guideline. Two guideline leaders (MTh for ESPGHAN 
and AT for ESGE) invited the listed authors to participate in the project. The key questions were prepared 
by the coordinating team (AT, MTh, MMT, RF, YV, JMD) and then approved by the other members. The 
coordinating team established task force subgroups, each with its own leader, and assigned the following 
key topics among these task forces: esophagogastroduodenoscopy (EGD) and ileo-colonoscopy (IC); 
foreign bodies (FB); corrosive ingestion; corrosive ingestion and esophageal strictures/stenoses; GI 
bleeding; endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasonography 
(EUS). Each task force performed a systematic literature search to prepare evidence-based and well-
balanced statements on their assigned key questions. Searches were performed in PubMed and/or 
EMBASE and/or Cochrane (publication year from 2000 to May 2015 or before if strictly needed) including 
as a minimum the key words „pediatric‟ and „endoscopy‟. All articles studying the application of diagnostic 
and therapeutic endoscopy in the pediatric age range were selected by title or abstract. The results of the 
relevant publications were summarized in literature tables and graded by the level of evidence and strength 
of recommendation according to the GRADE system (Grading of Recommendations Assessment, 
Development and Evaluation) [4,5]. Each task force proposed statements on their assigned key questions 
which were discussed and voted on during the plenary meeting held in February 2015 in Munich. In 
November 2015, a draft prepared by AT, CH and MTh was sent to all group members. After agreement 
from all the authors on a final version, the manuscript was reviewed by two members of the ESGE 
Governing Board, ESGE individual members and the ESPGHAN Council. The manuscript was then 
submitted to the Journal of Pediatric Gastroenterology and Nutrition for publication in full length, and to 
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Endoscopy for publication of an executive summary. Both the Guideline and Executive summary were 
issued in 2016/17 and will be considered for review and update in 2021/22 or sooner if new and relevant 
evidence becomes available. Any updates to the Guideline in the interim will be noted on the ESPGHAN 
and ESGE and websites: http://www.espghan.org/guidelines/; http://www.esge.com/esge-guidelines.html 
 
ESOPHAGO-GASTRO-DUODENOSCOPY (EGD) 
 
ESGE/ESPGHAN suggest diagnostic and therapeutic EGD for the indications listed in Tables 1 and 2, 
respectively.  
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN do not suggest EGD in the case of uncomplicated gastroesophageal reflux, functional 
gastrointestinal disorders or for diagnosing perforation.  
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest routine tissue sampling even in the absence of visible endoscopic 
abnormalities in all children undergoing EGD. 
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest using ESPGHAN guidelines (eosinophilic esophagitis, eosinophilic 
esophagitis, Helicobacter pylori (H. pylori), celiac disease (CD), and [IBD])) for precise indications and 
preferred sites for biopsy during EGD in children suspected of a specific disease. (Table 3) 
 
ESGE/ESPGHAN suggest performing EGD in children under general anesthesia (GA) or, only if GA is 
not available, deep sedation in a carefully monitored environment. 
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(Weak recommendation, low quality of evidence) 
ESGE/ESPGHAN suggest performing EGD in a child-friendly setting with appropriate equipment and 
by an endoscopist trained in pediatric gastroenterology. 
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest that when adult endoscopists perform pediatric procedures, collaboration 
between adult gastroenterologists and pediatricians is always warranted. 
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest that the choice of the gastroscope type should depend on the child’s weight 
and age (Table 4). 
 
EGD is a useful diagnostic and therapeutic tool in children [6], from which information can be obtained 
from visualization and biopsy of the mucosal surfaces of the esophagus, stomach and  duodenum. Although 
one third of children have a sore throat or hoarseness after EGD, EGD is generally considered to be safe for 
all ages [7]. In a pediatric cohort including 345 procedures (231 EGD alone, 26 colonoscopy alone, 44 
combined EGD and colonoscopy) in 301 children with a median age of 7 years, 20 (5.8%) adverse events 
were reported (12 secondary bleeding following variceal banding/sclerotherapy, 2 colonoscopy-related 
perforations, 6 anesthesia-related)  [8]. Fourteen events were procedure-related (12 secondary bleeding 
after banding or sclerotherapy, 2 bowel perforations during colonoscopy) and 6 were anesthesia/sedation 
related.  None of the adverse events were fatal.  However, it is important in order to minimize risk of 
complications, that EGD only should be performed for appropriate indications and by well-trained 
endoscopists [6]. A diagnostic EGD is indicated in the presence of symptoms listed in Table 1 in order to 
confirm an underlying disease. A selection of therapeutic indications are also listed in Table 2. Non-
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indications are uncomplicated gastroesophageal reflux and functional GI disorders. Contraindications 
include diagnosis of perforation (Table 1). 
Routine tissue sampling according to the indication, even in the absence of visible endoscopic 
abnormalities, is of major importance in all children undergoing EGD. Two studies in children assessed the 
value of routine esophageal, gastric and duodenal biopsies and new diagnoses based on biopsy samples 
alone were identified in 17% and 11% [9,10]. A study including 823 infants younger than 1 year of age, a 
group in which both symptoms and signs are notoriously difficult to interpret, the histological findings 
during EGD and/or colonoscopy were helpful in diagnosis in 63.8% of the cases [11]. One pediatric study 
showed that biopsies from the first and third part of the duodenum were important when assessing a patient 
for suspected celiac disease: biopsies from the duodenal bulb had an incremental diagnostic yield of 10.6% 
compared with biopsies only from the third part of the duodenum [12].  Table 3 sets out the ideal location 
for biopsies to allow the greatest diagnostic yield with respect to suspected diagnosis [2,13-15]. In contrast 
to adults, in children EGD should be performed with GA or, if not available, under deep sedation with a 
specifically trained pediatrician in charge only of the sedation leaving the endoscopist to concentrate on the 
procedure alone. Propofol-based sedation is likely to be the safest and most convenient way of sedation 
however this remains the subject of debate [16]. Furthermore, endoscopy should be performed in a child-
friendly setting. This is a very important point and pertains to not only the child but the family. The 
„journey‟ that a child and their parents/carers take should involve wherever possible a pre-visit to the unit, a 
play specialist to allow an age-specific approach to prepare the child, a non-threatening environment with 
age-appropriate wall decorations and toys, an anesthetist with the requisite human skills to allay the fears of 
the child and their family and a recovery area that is child-specific with parents/carers invited to be present 
before their child fully wakes. A multidisciplinary team consisting of a pediatric anesthetist, pediatric 
gastroenterologist, endoscopic nurse and specialized pediatric nurses, should be available to take care of the 
specific needs of pediatric patients. In some hospitals, adult endoscopists are needed to perform advanced 
therapeutic procedures which are not routinely performed by a pediatric gastroenterologist and these are 
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dealt with further on in this Guideline, however the advanced training of pediatric endoscopists is occurring 
and it is envisaged that upper GI endo-therapeutic procedures in the near future in children will and should 
be performed routinely by such individuals, as already occurs in a small number of supra-regional centers 
at present. A retrospective study suggested that „adult‟ endoscopists when supported by pediatricians are 
able to safely conduct EGD and IC in children but this Guideline Group suggest that this should not be the 
ideal arrangement and that pediatric endoscopists should manage the child and perform the procedure 
thereby providing a seamless service [17]. The choice of the equipment including the actual endoscope 
depends on a child‟s weight and age. Table 4 details the different endoscope sizes as adapted from 
American Society for Gastrointestinal Endoscopy (ASGE) [18]. 
 
ILEO-COLONOSCOPY  
 
ESGE/ESPGHAN suggest ileo-colonoscopy for the diagnostic and therapeutic indications listed in Table 
5.  
 
ESGE/ESPGHAN suggest against ileo-colonoscopy in the case of toxic megacolon, recent colonic 
perforation (<28 days), recent intestinal resection (< 7 days) or functional GI disorders.  
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest performing ile-ocolonoscopy in children under GA or, only if GA is not 
available, deep sedation in a carefully monitored environment.  
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest that ileo-colonoscopy should be performed in a child-friendly setting with 
appropriate equipment and by an endoscopist trained in pediatric gastroenterology. 
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ESGE/ESPGHAN suggest that when non-pediatric endoscopists perform pediatric procedures in older 
children, collaboration with a pediatrician is always warranted. 
(Weak recommendation, low quality of evidence) 
 
ESGE/ESPGHAN suggest that the choice of the colonoscope type should depend on child’s weight and 
age (Table 4). 
 
In children, IC is primarily indicated for suspected IBD, in cases of per-rectal bleeding and/or unexplained 
anemia [6] and for genetic polyposis syndromes including familial adenomatous polyposis (FAP) [19-21] 
(Table 5). The recommendations concerning environment, endoscopists and type of endoscopes are similar 
to those formulated for EGD. There are no published data to support specific colonoscope choice in 
children but recommendations based on experience state that the lower weight limit for use of a standard 
adult colonoscope is around 10 kg (Table 4). The largest safety report was a 5-year retrospective database 
study of 7792 procedures with an overall complication rate of 1.1% of which approximately 50% were GI-
related, most commonly bleeding, 30% were cardiopulmonary complications, and 10% were miscellaneous 
which included allergic drug rash reactions amongst others. Perforation was very uncommon (0.01%) [22] 
and as in adults, perforations in children are mostly due to advancement of the endoscope itself or are 
related to polypectomy, not to biopsy.  
 
BOWEL PREPARATION FOR ILEO-COLONOSCOPY IN CHILDREN. 
 
ESGE/ESPGHAN recommend low-volume preparation for bowel cleansing in children, using either 
polyethylene glycol (PEG) plus ascorbate or picosulphate magnesium citrate/Senokot. 
(Strong recommendation, high quality of evidence) 
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ESGE/ESPGHAN recommend against the use of sodium phosphate for bowel cleansing. 
(Strong recommendation, high quality of evidence) 
 
Success and safety of IC relies very much on the quality of bowel preparation. In adults, ESGE Guidelines 
recommend a low-fiber diet on the day preceding ileo-colonoscopy and a split regimen of 4L PEG solution; 
alternatives include a split regimen of 2L PEG plus ascorbate or of sodium picosulphate plus magnesium 
citrate [23]. The ESGE advised against the use of oral sodium phosphate due to the risk of renal 
insufficiency. Furthermore, PEG is the only recommended regimen in patients with renal failure [23]. In 
children, a national working group performed a systematic review and a national-based survey of all 
endoscopy units performing IC in Israel [24]; six different protocols were compared but none of these 
showed significant advantages. Another publication concluded that the most used agents in children include 
PEG-3350 solutions, picolax, senna, bisacodyl, and magnesium salts [25]; their efficacy was found to be 
similar. Recently a randomized controlled trial (RCT) including 299 children evaluated four different 
regimens [26]: the three low-volume regimens were non-inferior in terms of bowel cleansing compared 
with the “high-volume” regimen (PEG at a dose of 100 ml/kg, maximum 4 L). Of note, low-volume 
regimens were better tolerated and were associated with a less frequent need for nasogastric tube placement 
compared with the high-volume regimen. The authors suggested that the most suitable low-volume 
preparation was sodium picosulphate plus magnesium citrate. Regimens using sodium picosulphate with 
magnesium citrate (sodium picosulfate 0.01 g, magnesium oxide 3.5g, citric acid 12.0g per sachet) are used 
as follows: two doses 5-10 hours apart (0.25 sachet/dose for <6 year, 0.5 sachet/dose for 6-12 years, 1 
sachet/dose for >12 years) with liberal drinking of clear fluids such as cold tea/sport drinks and 
approximately 40 ml/kg after each dose. 
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ILEO-COLONOSCOPY IN CHILDREN: BIOPSY, CARBON DIOXIDE INSUFFLATION, ILEAL 
INTUBATION, POLYPECTOMY TECHNIQUE. 
 
ESGE/ESPGHAN suggest routine biopsy even in the absence of visible endoscopic abnormalities in all 
children with suspected IBD undergoing ileo-colonoscopy. 
 
ESGE/ESPGHAN suggest using ESPGHAN guidelines relating to ulcerative colitis and the revised 
Porto criteria for diagnosis of IBD for precise indications and preferred sites to biopsy. 
 
ESGE/ESPGHAN did not find any evidence to recommend against or for the use of routine CO2 
insufflation during IC in children. Pain seems to be rare and mild after IC in children.  
 
ESGE/ESPGHAN suggest that ileal intubation should be attempted in symptomatic children with 
abdominal pain, intestinal bleeding, diarrhea or with any suspicion of IBD.  
 
ESGE/ESPGHAN suggest removal of very small polyps (<3 mm) by cold biopsy forceps and 3-8mm 
polyps by hot or cold snaring. Cold snaring is advisable in the right colon where the perforation risk is 
higher. For polyps >8 mm, hot snaring is suggested. 
 
 
A study on 390 pediatric ileo-colonoscopies reported 84% agreement between endoscopists and 
pathologists, especially when an endoscopist reports normal-appearing colonic mucosa and if histology was 
considered the gold standard, endoscopy was found to have a 90% sensitivity and 78% specificity [27]. 
When children present with diarrhea, abdominal pain, weight loss or other symptoms where initial 
investigations are normal and in the absence of macroscopic lesions of the colon,  biopsies should be taken 
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from different colonic segments in order to exclude conditions such as collagenous or microscopic colitis 
[28]. Collagenous colitis is rare in children. One very small study found that 5/26 children with chronic 
diarrhea and macroscopically normal colonic mucosa had histological abnormalities (3 lymphocytic colitis 
and 2 collagenous colitis) [29]. In suspected pediatric IBD, recent ESPGHAN Guidelines highlighted the 
importance of biopsies in all segments of the lower digestive tract in order to differentiate Crohn‟s disease 
from ulcerative colitis and to determine the extent of the inflammatory process [3,15]. At the initial 
diagnostic stage, the presence of a granuloma allows differentiation between Crohn‟s disease and ulcerative 
colitis and when combined with EGD can make this distinction in up to 15-20% of cases over and above 
that which is made by IC alone [30]. Granulomas are more frequently observed when the biopsies are 
performed at the edges of ulcerative lesions [31,32]. In severe acute colitis, a careful examination limited to 
the rectum and sigmoid may be performed initially because of the risk of perforation when the risk/benefit 
is managed by the possibility of performing a subsequent IC [3]. Other pathologies such as acute graft-
versus-host disease (GVHD) can be safely investigated using endoscopy and in one retrospective study of 
48 children a sensitivity of recto-sigmoid biopsies of 77% for GVHD diagnosis was reported [33]. Biopsies 
taken proximal to the recto-sigmoid only contributed to the GVHD diagnosis in 2/48 however. This 
compares to a study of adults with acute intestinal GVHD in the lower GI tract, of whom 20% had lesions 
only in the ileum [34]. To increase the sensitivity of endoscopic exploration for suspected intestinal GVHD, 
a lower GI endoscopy may be accompanied by an EGD. 
Two meta-analyses studied the usefulness of CO2 insufflation during colonoscopy in adults [35,36]. Both 
found that CO2 insufflation significantly reduced pain during and after colonoscopy [35,36]. In a 
retrospective pediatric population, post-IC pain was reported using CO2 only by 2/68 (3%) children [37]. A 
recent RCT [38] compared insufflation of CO2 versus air during IC in children 7 to 18 years of age: CO2 
insufflation significantly decreases post-procedural discomfort. CO2 has been used in large series of double 
balloon enteroscopy (DBE) in children as the rapidity of gas reabsorption is particularly useful during this 
procedure - no adverse events such as clinically significant rise in blood CO2 were identified [39,40]. 
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Caution should be taken in small children because the amount of insufflated CO2 could induce adverse 
effects due to the smaller blood volume of young children. 
A registry of newly diagnosed IBD cases in children in 44 centers in 18 countries reported a successful 
intubation of the ileum in 75% of 1995 colonoscopies [41]. In an adult study of 500 consecutive 
colonoscopies where the ileum intubation rate was 99%, time and probability of ileal intubation were 
significantly correlated to the quality of bowel cleansing and to the experience of the endoscopist [42]. In a 
pediatric cohort of 44 complete colonoscopies with an ileal intubation rate of 61%, ileal examination did 
not modify the patient-reported symptoms after endoscopy but this is essentially irrelevant as the diagnosis 
clearly needs to be established histologically in order to inform subsequent management [37]. The aim of 
100% terminal ileum intubation is to be highlighted in children especially in the IBD situation [43].  
 
Polyps 
In a study including 11637 children, polypectomy was performed in 6.1% of procedures and this rose to 
12% where lower intestinal bleeding was a symptom [44]. Performing a polypectomy, the endoscopist has 
3 goals: to remove the lesion; to retrieve it for histological examination; and to avoid adverse events. The 3 
main adverse events of polypectomy are bleeding, perforation and post-polypectomy syndrome, also 
known as trans-mural burn syndrome. The specific technique of polypectomy is generally chosen based on 
polyp localization, morphology and size. In an RCT adult study, the use of a cold snare vs cold forceps 
polypectomy to remove diminutive (≤ 5 mm) polyps was significantly correlated with a shorter procedure 
time and a more complete polyp eradication rate (93% versus 76%, respectively). [45] Cold snaring is a 
safe technique with no adverse events reported in large series in adults [46]. Hot biopsy forceps on the 
other hand induced a larger histological lesion compared to conventional snare procedure in a porcine 
model, especially when the snare diameter is large (5 mm versus 2.5 mm) [47] and necrosis depth is 
increased after hot forceps polypectomy with a more frequent inflammatory reaction under the submucosa 
due to the smaller area for electrical current diffusion vs polyp snares.  Cytological artefacts are more 
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frequent in polyps removed by hot forceps technique compared to cold forceps [48]. For both of these 
reasons it is suggested that hot forceps polyp removal should be avoided in children. 
 
FOREIGN BODY INGESTION 
ESGE/ESPGHAN recommend an early referral to the emergency room and X-ray evaluation in all 
patients with suspected foreign body ingestion even if asymptomatic. Biplane radiographs should be 
obtained of the neck, chest, abdomen, and pelvis if indicated. Computed tomography (CT) scan can be 
considered for radiolucent foreign bodies (FB). 
(Strong recommendation, moderate quality of evidence) 
 
ESGE/ESPGHAN suggest early EGD if the foreign body is in the esophagus.  
 
The approach to the endoscopic management of foreign bodies should take in to consideration the type 
(food, batteries, magnets, sharp, blunt, drug packets and size), the symptoms, the time since probable 
ingestion, the probable GI location, any suspected impaction etc. In the case of batteries symptoms are 
immaterial especially if the battery is impacted in the esophagus. Indeed any patient who is symptomatic 
with an ingestion of a sharp or a blunt FB should have endoscopic removal attempted. The standard 
approach to resuscitation of Airway, Breathing and Circulation (ABC) is pertinent in this clinical context. If 
drooling is present and the patient is not able to swallow their secretions, there is a risk of aspiration. In 
cases of proximal esophageal FB ingestion, it will be necessary to ensure airway protection and endoscopy 
for FB removal should be performed under GA [49]. 
FB ingestion leading to impaction and food bolus impaction are quite common and the majority occur in 
the younger child with a peak incidence between the ages of 6 months and 6 years [49]. 
Pre-endoscopic series have shown that 80% or more of FBs will pass without the need for any intervention. 
Mortality due to FB ingestion was not reported in a large pediatric series [50,51]. A case of death has been 
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reported in a 2-year old boy due to an aorto-esophageal conduit caused by an impacted sharp FB in the 
esophagus [52].The patient‟s age and size, the type and form of the ingested object, its location as well as 
the clinical symptoms and duration since ingestion will all contribute to the decision whether to intervene 
endoscopically and to the timing of any intervention. 
Symptoms associated with FB ingestion varied among studies from vomiting, drooling, dysphagia, 
odynophagia, globus sensation and also included respiratory symptoms of coughing, stridor and choking. 
Some children are completely asymptomatic. In 9/12 studies [53] where coins were most the most frequent 
or only FB ingested, vomiting and drooling were the predominant symptoms. It should also be remembered 
that evaluation for peritonitis or small-bowel obstruction should occur in any case of FB ingestion and in 
such situations endoscopy should not delay surgical consultation but simultaneous endoscopy can 
complement the surgical approach [49,54,55].  
For the purpose of initial diagnosis, radiographs can confirm the location, size, shape, and number of 
ingested FB and can help to exclude aspirated objects [49,56]. Radiographs identify most radio-opaque FBs 
but radiolucent FBs are common, limiting the reliability of radiographs in this initial evaluation [56]. Fish 
bones, wood, plastic and thin metal objects are some of the most common radiolucent objects [49,56]. Thin 
fragments of aluminum, such as pull-tabs or pop-tabs of beverages, present a relatively high radiolucency 
[57]. Biplane radiographs should be obtained of the neck, chest, abdomen, and pelvis if indicated. In 
addition to localization of radio-opaque objects, the presence of free mediastinal or peritoneal air should be 
assessed. A contrast examination should not be performed routinely in the patient with suspected proximal 
esophageal obstruction because of the risk of broncho-aspiration. Furthermore, opaque contrast agents, 
such as barium, coat the FB and esophageal mucosa, compromising subsequent endoscopy and 
Gastrografin
® 
(amidotrizoeacid), a hypertonic non-opaque contrast agent, which can produce a severe 
chemical pneumonitis if aspirated, should not be used. There are no pediatric studies evaluating CT-scan in 
the diagnosis of FB ingestion in the digestive tract. A pediatric study [58] showed a 93% PPV and 100% 
NPV using spiral and cine CT-scan in the diagnosis of radiolucent FBs in the airways. CT scanning can be 
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considered in the diagnosis of radiolucent  ingested FBs in selected cases considering also the risk of X-ray 
exposure in children.There is not enough evidence for use of metal detectors or ultrasonography in 
localizing ingested coins in children [59,60]. Magnetic resonance imaging is not helpful in detecting FBs 
[61]. 
 
 
BLUNT FOREIGN BODIES AND COINS 
 
ESGE/ESPGHAN recommend removal of blunt FBs and coins or impacted food from the esophagus 
urgently (<24 hours), even in asymptomatic children. If the child is symptomatic an emergent (<2 hours) 
removal is indicated especially for button batteries. 
 
ESGE/ESPGHAN suggest removal of blunt FBs from the stomach or duodenum if the child is 
symptomatic or if the object is wider than 2.5 cm in diameter or >6cm in length. Otherwise blunt FBs in 
the stomach can be followed and retrieved only if they produce symptoms or do not pass spontaneously 
after 4 weeks. 
 
As noted above the timing of endoscopy depends on a number of factors including age, the patient‟s 
clinical status, the time of the patient‟s last oral intake, type of FB ingested, location within the GI tract and 
the time that has elapsed since ingestion. In addition, an assessment of the relative risk of aspiration, 
obstruction or perforation may determine the timing of any endoscopy [49]. Generally speaking, timing can 
be divided into emergent (less than 2 hours from presentation, regardless of nil by mouth status), urgent 
(less than 24 hours from time of ingestion) and elective (more than 24 hours from ingestion). Patients who 
are clinically stable without symptoms of proximal esophageal obstruction do not require emergent 
endoscopy because the ingested FB will usually pass spontaneously [49]. However, even in asymptomatic 
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children esophageal FBs and food that has impacted in the esophagus should be removed urgently (<24 
hours from presentation) as any delay decreases the likelihood of successful removal and increases the risk 
of adverse events, including the risk of perforation. These data are based on adult studies as those in 
children are not available [49,62,63]. If the FB is located in the stomach and there is no risk of impaction 
distally (for example due to strictures) then most FBs will pass in 4 to 6 days. Therefore conservative 
outpatient management is appropriate for most asymptomatic gastric FBs. If a child with a FB ingestion is 
being followed on an out-patient basis he/she should continue a regular diet and the child and their parents 
should be instructed to observe the stools for evidence of having passed the object and they should be 
advised that small blunt objects (including coins) may take as long as 4 weeks to pass spontaneously. Coins 
are the most common ingested FB objects among children but radiologically can be mistaken for button-
batteries (BB) and therefore a careful history is mandatory [64,65]. A child with witnessed or suspected 
ingestion of a coin or another blunt FB should undergo radiography as mentioned above. One should not 
mistake a coin for a BB therefore it is essential to closely examine the edges of the image of the coin on the 
Xray to exclude the double halo sign of a possible button battery.Lateral films also can be helpful to 
distinguish one from the other. 
Localization of the ingested coin in the GI tract, age of the child and coin size all are factors that influence 
the likelihood of spontaneous passage. Depending on the localization in the child‟s esophagus spontaneous 
clearance occurs in about 30-60% of children and is more likely if the coin is stuck in the distal esophagus 
at the time of diagnosis [66,67]. 
Blunt FBs and coins stuck in the esophagus should be removed urgently (within 24 hours) to avoid 
significant esophageal injury or erosion into the mediastinum and as detailed below BBs require emergency 
(<2 hours) removal from the esophagus - this also applies to other FBs if the patient is symptomatic, unable 
to manage secretions or with respiratory or other concerning symptoms. A radiograph should be repeated 
immediately prior to GA in order to avoid an unnecessary procedure in case the FB has spontaneously 
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passed through the esophagus but this should not delay emergency endoscopy in the case of a disc/button 
battery [68].  
Large or long objects which do not pass the pylorus and are trapped in the stomach should be removed 
electively or urgently in the case of a symptomatic child. There exists only expert opinion regarding the 
definition of “large” and “long” FBs. If the diameter of the FB is more than 2.5cm it is unlikely to pass the 
pylorus, especially in younger children. In one adult study [49], 80% of FBs longer than 6cm were unable 
to pass the pylorus in the 48 hours following presentation. Furthermore it is unlikely that FBs longer than 
6cm in length will pass from the first to the second part of the duodenum and are equally unlikely to pass 
through the ileo-cecal valve if the duodenum is traversed [49,68]. After each extraction one should examine 
the mucosa to exclude significant injury. 
 
SHARP POINTED OBJECTS 
ESGE/ESPGHAN recommend emergent (<2 hours) removal of sharp-pointed objects located in the 
esophagus (all cases). 
 
ESGE/ESPGHAN recommend emergent (<2 hours) removal of sharp-pointed objects in the stomach or 
proximal duodenum even in asymptomatic children. 
 
There are many reports of ingested sharp objects in children [69-71].The frequency and type of ingested 
sharp objects are highly dependent on cultural and environmental factors. One can see more young children 
with fish bone ingestions in Asian and Mediterranean families, where fish is a main food and introduced 
early in life [72]. Symptoms of ingestions are quite common if the FB is lodged in the upper-mid esophagus 
(pain, dysphagia, odynophagia, drooling). However a significant percentage of patients remain 
asymptomatic for weeks and delayed intestinal perforation, extra-luminal migration, abscess, peritonitis, 
fistula formation [68,73-75], appendicitis, liver, bladder, heart, and lung penetration [76-78] and rupture of 
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the common carotid artery [79]  have been described. The ileo-cecal region is the most common site for 
intestinal perforation but perforations have been reported in the esophagus, pylorus, at the junction between 
the first and second parts of the duodenum and in the colon [80]. Rates of complications are higher in 
patients who are symptomatic, have a delay in diagnosis beyond 48 hours [81] or have swallowed a 
radiolucent foreign body [82,83]. Toothpick and bone ingestions present a high risk of perforation [76,82] 
and are the most common FB that require surgical removal [82]. Patients suspected of having swallowed 
sharp-pointed objects must be evaluated to define the location of the object. Many sharp-pointed objects are 
not visible by radiographs, so endoscopy should still follow a radiologic examination with negative 
findings when a high index of suspicion is present. Sharp-pointed objects lodged in the esophagus are a 
medical emergency due to the potentially high risk of perforation and migration. Direct laryngoscopy is an 
option to remove objects lodged at or above the cricopharyngeus. Otherwise, flexible endoscopy may be 
performed if laryngoscopy is unsuccessful and for treatment of objects lodged below this area. Sharp-
pointed objects in the stomach or proximal duodenum should also be removed emergently but if these pass 
through the duodenum then enteroscopy, if available, or surgery, in a symptomatic patient must be 
considered. If observation rather than removal is chosen in the asymptomatic patient, then monitoring in a 
hospital setting with daily abdominal X-ray may be considered. Patients should be instructed to 
immediately report abdominal pain, vomiting, persistent temperature elevations, hematemesis or melena 
[61,71]. The average transit time for a foreign object ingested by children has been reported as 3.6 days 
[70] and the mean time from ingestion of a sharp object to perforation has been reported as 10.4 days [84]. 
If the foreign body has not progressed on imaging in three days or the patient becomes symptomatic, 
surgical removal may be considered [70,84]. 
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BATTERIES 
 
ESGE/ESPGHAN recommend to emergently (<2 hours) remove BBs impacted in the esophagus. 
 
ESGE/ESPGHAN suggest to remove BBs in the stomach emergently (<2 hours) if the child is 
symptomatic and/or has a known or suspected anatomical pathology in the GI tract (e.g. Meckel’s 
diverticulum), and/or has simultaneously swallowed a magnet. 
 
ESGE/ESPGHAN suggest that BBs larger than >20 mm present in the stomach should be checked by 
radiograph and removed if still in place after more than 48 hours. 
 
ESGE/ESPGHAN recommend an urgent endoscopic removal (< 24 hours) for single cylindrical battery 
ingestion when impacted in the esophagus and as soon as possible elsewhere in the GI tract when the 
child is symptomatic (Strong recommendation, moderate quality of evidence)  
 
ESGE/ ESPGHAN suggest that a single cylindrical battery in the stomach can be observed and the child 
monitored as an outpatient and followed by X-ray 7-14 days after ingestion if the battery is not passed in 
the stool. 
 
BBs and Cylindrical Batteries 
The US Poison Centers, from 1985-2009, reported an incidence of 6.3-15.1 cases of batteries ingested per 
million population [85,86].  
An observed increase in poor outcome was attributed to the emergence of the larger, 20-mm diameter, 
lithium coin cells as an increasingly popular battery type. Thirteen deaths related to tissue damage in the 
esophagus or airway and 73 major outcomes (with debilitating and prolonged compromise of feeding 
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and/or breathing that required multiple surgical procedures, enteral tube feeding and/or tracheostomies) 
were described [85,86]. These devastating cases occurred predominantly in children who were younger 
than 4 years [85,86]. Almost all of these major outcomes involved esophageal BB injuries and therefore 
impaction at this site represents the highest risk for injury and this leads to our recommendation to 
emergently (<2 hours) remove BB impacted in the esophagus [87]. The removal of BBs in the stomach is 
controversial. The largest retrospective study of 8648 cases is reassuring with no reported significant 
gastric injuries from BB ingestion [85]. However there are case reports of severe gastric injury [88] and 
also fatalities reported from aorto-esophageal fistulae due to gastric BBs that had caused esophageal injury 
before reaching the stomach [89]. The recommendation with respect to removal of BBs from the stomach is 
based on expert opinion and in the knowledge that only two cases of BB-induced gastric lesions have been 
reported during the last 30 years. Consistent with other guidelines [49] BBs larger than 20mm in the 
stomach should be checked by radiography and removed if still in place after more than 48 hours. Less 
evidence exists regarding cylindrical battery ingestion and although these batteries do not typically 
discharge electrical current in the way that BBs do they nevertheless have the potential to leak caustic fluid 
if the outer casing is compromised. In the largest published series identified of 62 children with cylindrical 
battery ingestions, about 82% were unaffected and no patient had major complications or death. [90]  Of 
particular interest to the practitioner caring for adolescents, a suicide attempt was the reason for ingestion in 
only 1.3% of the 2,382 total battery ingestions in this series, which is lower compared with other objects or 
poisons sought out for the same purposes [91]. For single cylindrical battery ingestions we suggest urgent 
endoscopic removal (<24 hours) when impacted in the esophagus but if located in the stomach the patient 
can be monitored as an outpatient and followed by X-ray if the battery is not observed to pass in the stool. 
Once these batteries pass the pylorus they almost universally pass the remainder of the GI tract without 
incident. For the adolescent with multiple gastric cylindrical batteries as the result of intentional ingestion 
one paper advocates endoscopic removal of the batteries at the time of presentation [92]. 
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MAGNETS 
ESGE/ESPGHAN recommend urgent (<24 hours) removal of all magnets within endoscopic reach. For 
those beyond endoscopic reach, close observation and surgical consultation for non-progression through 
the GI tract is advised. 
 
Ingestion of a single magnet is typically innocuous and would be expected to behave much like another 
blunt FB. In contrast, multiple magnets or a magnet and another metallic FB can lead to bowel wall 
necrosis with fistula formation, perforation, obstruction, volvulus or peritonitis [93] by attracting 
themselves and trapping a portion of the bowel wall. 
 
FOOD BOLUS IMPACTION 
ESGE/ESPGHAN recommend removal of impacted food from the esophagus as an emergency 2 hours 
from the time of presentation (and ideally from the time of ingestion) in case of symptoms (drooling, 
neck pain). If the child is asymptomatic an urgent (< 24 hours) removal is indicated. 
(Strong recommendation, moderate quality of evidence) 
 
ESGE/ESPGHAN suggest investigation for underlying pathology of the esophagus in all cases of food 
impaction. 
(Weak recommendation, low quality of evidence) 
 
Food bolus impaction in the esophagus is the most common type of impaction in adults [94]. Data in 
children are rare but several studies show that underlying esophageal pathology, such as eosinophilic 
esophagitis, peptic or other strictures, achalasia and other motility disorders often are the cause of food 
bolus impaction [94-98]. Esophageal food bolus impaction in a symptomatic patient with drooling or neck 
pain is an indication for emergent endoscopic removal. If the child tolerates their secretions, endoscopic 
Copyright © ESPGHAN and NASPGHAN. All rights reserved.
removal may be postponed and an urgent (<24 hours) endoscopic removal may be considered, allowing an 
elective procedure and providing additional time for spontaneous clearance. The technique of removal can 
include piece-meal extraction, suction and/or gentle pushing of the bolus down into the stomach, though 
visualization of the distal esophagus is necessary to ensure that there is no stricture distal to the bolus. 
Use of glucagon to relax the lower esophageal sphincter to hasten spontaneous clearance has been studied 
with equivocal results and has not generally been recommended in this setting [99]. Recent data suggest 
that it may be particularly ineffective in cases with underlying eosinophilic esophagitis [68,99,100]. 
 
DRUG PACKETS 
ESGE/ESPGHAN recommend against endoscopic removal of drug-containing packets. 
(Strong recommendation, low quality of evidence) 
 
In regions of high drug trafficking, so called “body packing” can also involve teenagers. Illegal drugs are 
packed into latex condoms, balloons or plastic and swallowed for transportation [101]. Leakage or rupture 
of these packets can be fatal, therefore endoscopic removal should not be attempted. Surgical removal is 
indicated when packets fail to progress or if signs of intestinal obstruction are present. If packet rupture is 
suspected, surgery and urgent medical consultations for drug toxicity are indicated. 
 
EQUIPMENT FOR FOREIGN BODY REMOVAL 
ESGE/ ESPGHAN suggest that flexible endoscopy is an effective and safe procedure for removing FB 
from the GI tract, with a high success rate using retrieval nets, polypectomy snares and rat-tooth forceps. 
(Weak recommendation, very low quality of evidence) 
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Flexible Endoscopy 
Most ingested FBs are best removed using flexible endoscopes and have a high success rate. Chaves et al 
performed a prospective mixed child and adult study showing that flexible endoscopy is an effective and 
safe procedure to remove FBs from the GI tract, with a high success rate using only polypectomy snares 
and rat-tooth forceps [102]. 
 
Rigid endoscopy 
Some studies have shown that rigid esophagoscopy carries a higher complication rate than flexible 
endoscopy in performing esophageal FB extraction and its routine use is not recommended [103]. Rigid 
endoscopy can be considered only for proximally located blunt objects, since the rigid tube provides 
protection [103,104]. 
 
Magill Forceps 
In a retrospective study, coins located in the proximal third of the esophagus where successfully removed 
using Magill forceps. Using direct laryngoscopy under anesthesia coins were visualized and grasped with 
Magill forceps. The coin was removed in 96% of 165 children with a proximal esophageal coin, 82% at the 
first attempt [105]. 
 
Retrieval Devices/Overtubes 
 
Devices used for retrieving  FBs include alligator and rat-tooth forceps, retrieval nets, polypectomy snares, 
tripod forceps and baskets. The availability of latex cone and overtubes to protect the cardia and esophagus 
when removing sharp foreign bodies is important for procedure safety. There are no studies performed in 
children on the use of different retrieval devices or overtubes.  
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Pharmacological agents 
One RCT did not find an advantage in spontaneous passage of a coin from the esophagus to the stomach 
when using glucagon compared to placebo [106]. 
 
CORROSIVE INGESTION 
ESGE/ESPGHAN suggest that every child that has ingested a corrosive substance should have a 
thorough follow-up, with endoscopy dictated  by symptoms and dependent on the symptoms/signs, the 
timing should be within 24 hours. 
(Strong Recommendation, high quality of evidence) 
 
ESGE/ESPGHAN recommend that every child with a suspected caustic ingestion and symptoms/signs 
(e.g. any oral lesions, vomiting, drooling, dysphagia, hematemesis, dyspnea, abdominal pain etc) should 
have an EGD in order to identify all consequent digestive tract lesions. 
(Strong recommendation, high quality of evidence)   
 
ESGE/ESPGHAN suggest that in the case of suspected corrosive ingestion, EGD is withheld if the child 
is asymptomatic (no drooling of saliva/other symptoms and no mouth lesions) and that adequate follow-
up is assured. 
(Weak recommendation, moderate quality of evidence 
 
Ingestion of corrosive substances can cause serious injuries to the digestive tract and occurs most 
commonly in children (about 80% of the cases) [107,108]. Corrosive ingestion is mostly accidental in 
children (but intentional ingestion has been described in teenagers [109,110]) and although reported at any 
age it is more frequent under 5 years with a maximum incidence at 2 years of age [107,109]. In the 
developed world with the advent of child-unfriendly packaging, corrosive ingestion has become quite rare 
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[111]. Household, industrial and farm products, especially if stored in non-original containers, represent the 
most frequently ingested caustic agents.  
The ingested substance varies between rural and urban living areas and also with the level of economic 
development. In developing world  countries the most frequent accidental poisoning are medications 
(48.3%), followed by corrosive acidic substances (23.1%), carbon monoxide intoxication (12.5%) and 
batteries [112,113]. A variety of substances have been reported that were ingested leading to caustic 
injuries ranging from alkaline bases with pH up to 12 (e.g. sodium hypochlorite and sodium hydroxide), to 
acidic substances with a pH as low as 2 (e.g. hydrochloridic acid and salicylic acid) and also bleaching 
substances where the pH is around 7 [114,115]. More recently so-called hair-relaxers and liquid tabs (pods) 
containing detergents are a new addition to the long list of ingested products but fortunately it seems that 
the upper digestive tract is not as severely damaged by these substances [116,117]. 
The extent of the esophageal damage is related to the nature and the concentration of the caustic substance, 
the duration of contact with the mucosa and quantity ingested [118]. Strong alkalis produce liquefaction 
necrosis with deep ulcerations and risk of esophageal stricture and/or perforation. Acids usually cause 
coagulative necrosis with limited tissue penetration and superficial scar formation [119]. Upon swallowing, 
acids cause severe oropharyngeal pain and therefore they are usually consumed in small volumes compared 
with  alkaline substances [107], resulting in a lower incidence of stricture formation and/or esophageal 
perforation. Other substances that may result in stricture formation are bleaching agents, non-phosphoric 
detergents, ammonia and sodium bicarbonate.   
Gastric lesions, with or without outlet obstruction syndrome, are almost always related to acidic ingestions, 
as alkalis are neutralized by gastric acid [120]. 
If not actually observed then corrosive ingestion may be inferred from oral burns, however their absence 
does not exclude ingestion and esopohageal/gastric damage [121] and the consequent need for EGD. 
Although there are some discrepancies between studies, it is known that up to 70% of corrosive ingestions 
may be asymptomatic at presentation [120,122,123]. It has been proposed that routine EGD is not 
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performed in asymptomatic patients in the absence of oral lesions [119,124-126]. Drooling saliva and oral 
lesions have been noted significantly more frequently in high-grade injury and symptoms such as pain, 
hyper-salivation, swallowing difficulties and bleeding are other suggestive symptoms of esophageal injury 
[113,121]. Some children may even develop dyspnea and other respiratory symptoms (cough) and in very 
severe cases hemodynamic instability and/or circulatory collapse, however none of these presenting 
symptoms is completely predictive of esophageal injury [114], although hematemesis or dyspnea as single 
symptoms have a very high positive predictive value for esophageal lesions after caustic ingestion 
[122,124,126]. Both in retrospective and prospective studies, the presence of three or more symptoms that 
occurred after caustic ingestion was positively associated with severe lesions seen at EGD [124,126]. 
Young children presenting with suggestive symptoms in the absence of an observed ingestion of corrosives 
require EGD to exclude esophageal lesions [120,122-124,127,128].  
Esophageal lesions after corrosive ingestion are described according to the Zargar Classification [129]:  
 
Grade 0 Normal. 
Grade I Edema and hyperemia of mucosa. 
Grade IIa   Friability, hemorrhage, erosion blisters, exudates or whitish membranes, superficial ulcers. 
Grade IIb Grade IIa plus deep discrete or circumferential ulceration. 
Grade IIIa Small scattered areas of necrosis, areas of brownish-black or grey discoloration. 
Grade IIIb   Extensive necrosis. 
 
Images of the lesions are important for an accurate follow-up. 
Patients with low grade lesions at endoscopy (grade 0 to IIa) who have in addition a normal physical 
examination and  who can eat and drink normally can be discharged [126,127] but if not then admission to 
a hospital environment for observation should occur. 
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ESGE/ESPGHAN recommend to have the same grade of suspicion for both acidic and alkali ingestion 
regarding potential mucosal injury. (Alkali ingestion, especially lye, is associated with more severe 
esophageal lesions and severe gastric lesions can occur in acidic ingestion.) Stricture development has 
been associated with both acidic and alkali ingestion.  
 
ESGE/ESPGHAN recommend high doses of intravenous dexamethasone ((1g/1.73m2 per day) 
administration for a short period (3 days) in IIb esophagitis after corrosive ingestion as a method of 
preventing esophageal stricture development. There is no evidence of benefit from the use of 
corticosteroids in other grades of esophagitis (I, IIa, III)  
 
Efforts should be undertaken to prevent vomiting after corrosive ingestion. Small amounts of water can be 
allowed if the child asks for it or even stimulated to rinse the mouth and esophagus. However, if the child 
has severe pain and if perforation is suspected, nothing should be given by mouth. 
Experimental studies showed decreased incidence of grade III burns and stricture formation with early 
corticosteroid and antibiotic use compared with controls [119,130,131]. However, their efficacy and safety 
in children with esophageal burns is under discussion [132,133] because of many inconsistent variables 
including the type of corticosteroids used, the dosage and duration. A recent RCT has concluded that 
corticosteroids are beneficial for stricture prevention in grade IIb esophageal burns [131]. As yet unstudied 
is the possibility of the anti-fibrotic Mitomycin-C used topically to prevent post-ingestion fibrosis. 
 
BENIGN ESOPHAGEAL STRICTURES 
ESGE/ESPGHAN recommend esophageal dilation using balloon or bougies for benign esophageal 
strictures only when symptoms occur. 
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Esophageal strictures in children may have multiple etiologies including congenital or inflammatory 
disorders, caustic ingestion, eosinophilic esophagitis (EE) and gastroesophageal reflux disease (GERD) 
[134]. The relative proportions of etiologies vary between countries (e.g. higher proportion of caustic 
strictures in developing countries) [135,136].  
EE will not be discussed as this topic is covered by another recent Guideline [14]. Safety and long term 
efficacy of esophageal dilation for benign esophageal strictures has been confirmed in children [137,138]. 
Data on the ideal timing of esophageal dilation are scarce. Two retrospective studies including 100 and 76 
esophageal atresia (EA) patients compared routine esophageal dilation every three weeks starting three 
weeks post-surgery versus when symptoms developed. No difference in outcome and complications were 
found between the two groups after 2 and 3 years of follow-up but significantly fewer dilations were 
needed in the on-demand dilation group [139,140]. 
Through-the-scope balloons and wire-guided polyvinyl bougie dilators (Savary Gilliard) are most 
frequently used to dilate benign esophageal strictures in children and similar results are reported – a 
retrospective study [141] compared 125 balloon dilations vs 88 bougie dilations in children with benign 
esophageal strictures and reported 4 failures in the bougie group related to unsuccessful passage of the 
stricture. 
Expert opinion suggests that both anesthesiology and surgical assistance should be available during 
esophageal dilation procedures in children - the latter in case of complications [141]. 
 
Balloon dilation. 
Balloon dilation can be performed under direct endoscopic view or fluoroscopic view. The size of the 
balloon catheter can vary from 4-22 mm and the balloon inflation duration varies between studies from 20 
to 120 seconds [142]. A study [137] on 77 children (median age 1.8 years) that underwent 260 balloon 
dilations of benign esophageal strictures under endoscopic view (mean 3.4 dilations/patient), reported 4 
(1.5%) esophageal perforations, with one requiring surgery - the remaining patients were all asymptomatic 
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after a median follow-up of 6.6 years. Strictures shorter than 5cm in length appeared to have a significantly 
better outcome [143,144]. In a retrospective study of 34 patients with EA and symptomatic esophageal 
strictures, balloon dilation appeared to be more effective and less traumatic than bougienage [145]. 
 
Bougies 
Bougie dilation is a safe and effective dilation technique for esophageal strictures. In a study of 107 
children, dilation was performed at 2-3 week intervals using Savary-Gilliard bougies and was considered 
adequate if the esophageal lumen could be dilated to 15mm diameter (12mm in children <5 years of age) 
with complete relief of symptoms [146]. Subsequently, dilation was performed on an “as needed” basis 
dependent on symptoms. Dilation was successful in all but 3 cases. Dilation was also successful in patients 
with strictures 5cm or more in length and/or in patients with multiple corrosive strictures, although these 
required a higher number of sessions to achieve adequate dilation and also higher number of subsequent 
sessions for recurrence. Six esophageal perforations occurred during 648 dilation sessions (0.9%) with 1 
requiring surgical repair. 
 
Size, number and interval between dilations 
 There are no data on the “optimal” increase in size that should be aimed for at each dilation session. The 
„rule of three‟ is often invoked: no more than 3 times the diameter of the stricture - so a 3mm stricture 
should not be dilated to more than 9 mm etc. Balloons are to be preferred over bougies if financially 
possible. There exists no consensus in regard to the interval between dilations and the frequency of this 
intervention is often individualized according to relief of dysphagia and the severity of the stricture 
observed during repeat endoscopy. Most studies used a minimal period of three weeks between dilation 
sessions [144,146,147] and for balloon dilation an average of three dilations appeared to be required [142].   
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ESGE/ESPGHAN suggest the following definition of a benign refractory or recurrent stricture in 
children: "An anatomic restriction because of cicatricial luminal compromise or fibrosis that results in 
dysphagia in the absence of endoscopic evidence of inflammation. This may occur as the result of either 
an inability to successfully remediate the anatomic problem to obtain age-appropriate feeding 
possibilities after a maximum of 5 dilation sessions (refractory) with maximal 4-week intervals, or as a 
result of an inability to maintain a satisfactory luminal diameter for 4 weeks once the age-appropriate 
feeding diameter has been achieved (recurrent)".  
 
To define refractory and recurrent strictures in children, we adopted the definition used in adults based on 
Kochman‟s criteria [148]. In an online survey of the working group members, the number of sessions, 
intervals and target diameter were assessed. Seventeen of 18 members (94%) supported the definition 
stated above, with 39% and 61% of respondents mentioning a maximum of three and five sessions, 
respectively. Proposed intervals between sessions were: two or three weeks (39% of members each) or four 
weeks (22%). Refractory and recurrent stenosis is reported in about 30% of the cases [142].  
 
ESGE/ESPGHAN suggest temporary stent placement or application of topical mitomycin C (MMC) 
following dilation for refractory esophageal stenosis in children. ESGE/ESPGHAN do not suggest the 
routine use of intra-lesional steroids for refractory esophageal stenosis in children. 
  
There is no standard treatment for refractory stenosis.  
Local application of mitomycin C (MMC) is a therapeutic option for the treatment of refractory esophageal 
strictures in children [149,150]. A systematic review identified eleven publications including 31 cases [151] 
of various etiologies. In one study, cotton pledgets soaked in a solution (0.1mg/ml) of MMC were applied 
endoscopically directly onto the mucosa post-dilation with a frequency of 1-12 times over 12 weeks. After 
a mean follow-up of 22 (6 to 60) months complete relief of symptoms was reported for 21/31 children 
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(67.7%), and 6/31 (19.4%) had a partial relief. In four children (12.9%) MMC application failed. No direct 
or indirect adverse effects were reported. Two double blind RCTs showed that MMC application 
significantly reduced the number of esophageal dilations sessions needed to alleviate dysphagia following 
EA and corrosive strictures [152,153].   
MMC is a cytostatic agent, therefore dysplasia of healthy tissues after application should be considered as a 
theoretical risk. [151] This complication was not observed in a study performing esophageal biopsies 
during a 24 months mean follow-up [149]. Future studies with long-term follow up are required to evaluate 
the potential side effects [149,151]. 
 
With the advent of removable, fully covered, self-expandable metal stents (FCSEMS), the use of 
esophageal stents in children has expanded in particular for the treatment of refractory stenoses. In three 
studies that included a total of 25 children, complete clinical response following stent removal with no 
recurrence of dysphagia or need for subsequent dilations was reported in 50-85% of patients. [154] Most 
patients suffered from nausea or chest pain in the days following stent placement, in some cases leading to 
premature removal of the stent. Duration of stenting varied from 1 to 24 weeks. Stent migration was the 
most commonly cited complication and occurred in 0-29% of patients. In a recent retrospective study in 
children with perforations and refractory strictures after EA repair a total of 41 plastic and FCSEMS were 
placed in 24 patients, including 14 patients who had developed esophageal leaks. Success in the treatment 
of refractory strictures was limited due to a high stricture recurrence rate after stent removal (39% at 30 
days and 26% at 90 days). Stent-related adverse events included migration (21% of plastic and 7% of 
FCSEMS), granulation tissue (37% of FCSEMS and none of plastic), and deep ulceration (22% of 
FCSEMS and none of plastic) [155].  
A recent uncontrolled study in 10 children with intractable esophageal strictures due to caustic ingestion 
reported symptom resolution using stricture dilation preceded by intra-lesional triamcinolone injection 
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[156]. However, in a recent double-blind RCT in adults with benign anastomotic strictures, no benefit of 
intra-lesional triamcinolone could be demonstrated [157]. 
 
In patients operated for EA, ESGE/ESPGHAN suggest long-term endoscopic surveillance for Barrett’s 
esophagus and cancer. Frequency would be dictated by the presence or not of dysplasia and should 
follow standard guidelines already published in the literature. 
 
A systematic review and meta-analysis to define the prevalence of chronic long-term problems in 907 EA 
operated patients showed, compared with controls, a 40.3 relative risk for dysphagia during adolescence 
and adulthood due to altered peristalsis [158]. Gastroesophageal reflux is a known risk factor for 
subsequent development of esophageal intestinal metaplasia. The overall estimated prevalence of Barrett‟s 
esophagus was 6.4% in EA patients, which is 4 times and 26 times higher than its prevalence in adults and 
pediatric general population respectively. In a systematic review the prevalence of esophageal carcinoma 
was low (1.4%) and only squamous cell carcinoma was described. However, cases of adenocarcinoma in 
EA patients have been reported [159]. In view of the high incidence of Barrett‟s esophagus in EA patients 
at a young age [160], endoscopic surveillance is warranted in adolescence and adulthood [161]. The 
question of whether endoscopic surveillance should occur for metaplastic change following corrosive 
ingestion is not one that can be adequately answered with the present medical evidence. 
 
UPPER AND LOWER GI BLEEDING. 
ESGE/ESPGHAN suggest that, having employed all necessary medical interventions as standard, EGD 
be performed very early (<12 h) in acute upper GI bleeding (AUGIB) cases which require ongoing 
circulatory support or where a large hematemesis or melena occurs. 
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ESGE/ESPGHAN recommend that, having employed all necessary medical interventions as standard, 
EGD be performed very early (< 12 h) in AUGIB in cases with known esophageal varices. 
(Strong recommendation, moderate quality of evidence)   
 
ESGE/ESPGHAN suggest that, having employed all necessary medical interventions as standard, EGD 
be performed within 24 hours in AUGIB cases which require transfusion due to hemoglobin drop below 
8 g/dL, where an acute drop of 2 g/dL is identified, and in those who are stable but whose bleeding score 
is above a recognized threshold/validated score for probable endoscopic intervention requirement. 
 
ESGE/ESPGHAN suggest that EGD be performed before hospital discharge in children with AUGIB 
and pre-existing liver disease or portal hypertension. 
 
ESGE/ESPGHAN do not suggest routine use of wireless capsule endoscopy/enteroscopy in AUGIB in 
children. 
 
ESGE/ESPGHAN suggest that urgent therapeutic ileo-colonoscopy is not usually necessary in lower GI 
bleeding unless severe enough to cause circulatory compromise but diagnostic IC is needed as soon as is 
practical and safe. 
 
Adult studies are the primary guides for evaluation of pediatric practice, but are not entirely applicable to 
children. Distinction is drawn between the speed of intervention required for acute upper and lower GI 
bleeding in children. It is rare to require intervention for lower GI bleeding as the majority of massive 
hemorrhage (fresh red blood/melena) originates in the upper GI tract with the occasional exception of a 
Meckel‟s diverticulum or severe colitis.  
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Scoring systems of intervention in children are emerging but require prospective evaluation of predictive 
accuracy and reliability. 
In adults with AUGIB validated scoring systems have been published [162-164] while, to date, only one 
such scoring system exists in pediatrics („Sheffield Scoring System‟) which might predict the requirement 
or otherwise for endoscopic hemostatic therapy, is undergoing prospective multi-center validation at 
present [165]. This retrospective case-control study reliably predicted which children most likely require 
endoscopic intervention. Particular weighting was given on modelling to such factors as: transfusion 
requirement; signs of hypovolemia (raised HR> 20 bpm above age-appropriate median and prolonged 
CRT); large hematemesis; melena; and drop of Hb> 2 g/dl. The timing of such intervention is clearly 
dependent on the circulatory stability of the child. For uncontrolled bleeding requiring volume support 
immediate intervention is suggested. For children in whom the threshold score is reached but who are 
stable then endoscopic intervention within 12 hours is suggested. Finally, for children whose clinical 
bleeding risk score does not reach the intervention threshold and in whom AUGIB would appear to have 
ceased then elective or no endoscopy is suggested [165]. 
The matter is further complicated by the wide variability of the following important practical factors in the 
provision of such life-saving techniques for children: availability of appropriately trained pediatric 
therapeutic endoscopists; availability of units with adequate and appropriate equipment/skills within 
geographical proximity; and agreed guidelines/algorithms of care for this clinical emergency with, to date, 
no universal view of when and how to intervene endoscopically. 
This is further compounded by an absence of knowledge of the size of the clinical problem in pediatrics. 
Many pediatric endoscopists would not encounter an acute upper GI bleeding case more than a handful of 
times each year. A case, then, may be made for centralisation of such units and skills, but the caveat to this 
is the need then for safe transport of a child who may be actively bleeding to such a center. 
There seems to be little requirement for urgent or early use of the wireless capsule endoscope or 
enteroscopy in acute bleeding in children [40,166,167]. 
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Endoscopy has been advocated for the management of AUGIB, but the optimal timing is still uncertain. 
Ideally, endoscopy should occur after the stabilisation of the patient and various studies have been 
conducted comparing various timing of endoscopy performed within 6, 12 and 24 hours of presentation 
[168]. Adult literature recommend that endoscopy in AUGIB should be performed within 24 h of 
presentation [169,170] or within 12 hours when bleeding continues at a rate considered potentially life-
threatening [170-174]. A clinical benefit of endoscopy performed of presentation is reported in acute 
variceal bleeding in children [175]. In the pediatric population endoscopy in AUGIB is recommended 
within 24 hours [165,170,172].  
 
Lower GI Bleeding  
Most cases of acute colonic bleeding (or lower GI bleeding) in children presenting either as hematochezia 
(bright red blood, clots) or melena will stop spontaneously, thus not needing urgent evaluation [176], but IC 
following adequate bowel preparation need to be planned before discharge from the hospital. However, for 
children with severe hematochezia, defined as continued bleeding within the first 24 h of hospitalization 
with a drop in the hemoglobin of at least 2 g/dl and/or a transfusion requirement, urgent diagnosis and 
intervention are required to control bleeding [165,177]. When hematochezia is not severe, elective IC need 
to be scheduled.  
 
ENDOSCOPIC HEMOSTASIS TECHNIQUE FOR GI BLEEDING IN CHILDREN 
ESGE/ESPGHAN recommend hemostasis of esophageal variceal bleeding in children using band 
ligation, if feasible, or sclerotherapy as an alternative. 
 
ESGE/ESPGHAN suggest that the treatment of peptic ulcers and Dieulafoy’s lesion should not be 
carried out with epinephrine injection alone but in combination with thermal or mechanical techniques.  
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Minimal data exist comparing endoscopic equipment and techniques in children. Adult studies are the 
primary guides for evaluation of pediatric equipment. Working channel size is the major factor limiting the 
choice of accessories [18]. In children >10 kg, endoscopes for therapeutic endoscopy are generally identical 
to those used in adults (Table 4). 
Standard pediatric gastroscopes have a 4.9-6.0 mm outer diameter and a 2.0 mm working channel. They 
will accommodate needles for injection therapy (4-6 mm length), bipolar and argon plasma coagulation 
probes but not heater or multipolar probes, or ligating or mechanical devices [178]. Removing the Teflon 
sheath from a hemostatic clip allows use with pediatric endoscopes. Patient electrodes and grounding pads 
are available in neonatal (< 3 kg) and pediatric (< 15 kg) sizes. 
 
Non-variceal bleeding 
Dieulafoy lesion 
In a review of 24 pediatric cases, half were treated surgically, the others were managed endoscopically by 
injection therapy, band ligation and thermocoagulation [179]. Epinephrine combined with either 
mechanical treatment or heater probe is preferable to epinephrine alone for hemostasis [180]. One should 
consider tattooing the bleeding site to aid location in the event of re-bleeding [181].  
 
Bleeding ulcer 
A report describes the successful treatment of a newborn by heater probe thermocoagulation [182]. Argon 
plasma coagulation with a 1.5 mm or 2.3 mm probe was used in 12 children [183]. Generally, for older 
children standard adult GI practice should apply to AUGIB [184].  
 
Variceal Bleeding 
A randomized prospective study in 49 children showed that band ligation is safe and effective, superior to 
sclerotherapy in terms of variceal eradication and was associated with a lower re-bleeding rate [185].  Most 
Copyright © ESPGHAN and NASPGHAN. All rights reserved.
studies support band ligation but if that is impossible due to patient size then sclerotherapy can be used 
[185-187]. The use of band ligation sets for gastroscopes with a diameter of 8.5-9.2 mm is limited primarily 
by the narrowness of the pharynx, and not only by body weight. Recently band ligation sets are available 
for pediatric gastroscopes and although previously sclerotherapy was the method of choice for children 
weighing <8 kg [188] this may change soon. Evidence is limited concerning the management of gastric 
varices in children. In case reports, N-buthyl-2 cyanoacrylate „glue‟ injection has been successful 
[186,189]. Small cohort studies in children using variceal banding as prophylaxis exist [190]. It has been 
found that variceal grading can be a subjective assessment. There is no evidence that PPI use post-banding 
is beneficial [191]. A retrospective review of the safety and efficacy of expanded polytetrafluoroethylene-
covered transjugular portosystemic shunt in 12 children showed a satisfactory result and therefore this may 
be a useful alternative in acute or recurrent medically or endoscopically uncontrollable variceal bleeding 
[192]. 
 
ESGE/ESPGHAN suggest adopting general anesthesia in children undergoing endoscopy for GI 
bleeding. General anesthesia is recommended when there is variceal bleeding.  Deep sedation may be 
used in less severe bleeding in older children. 
 
ESGE/ESPGHAN suggest using video capsule endoscopy (VCE) in children when there is suspected 
small-intestinal bleeding and in addition balloon enteroscopy for therapeutic purposes. 
 
The majority of studies are retrospective analyses focusing on the diagnostic yield and therapeutic success 
of endoscopy in children with GI bleeding. The type of sedation/anesthesia used when performing upper GI 
endoscopy in children for AUGIB is not always reported, but most of the procedures were performed under 
GA with endotracheal intubation, while conscious or deep sedation should not be preferred [193].  
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VCE in children finds a main indication in the study of obscure GI bleeding and suspected or known 
Crohn‟s disease. The youngest VCE patient investigated was 8 months [194]. If the capsule cannot be 
swallowed it is placed endoscopically using various devices [166]. In a meta-analysis including 723 VCE 
examinations in children, the diagnostic yield of VCE was 65.4% with retention rates comparable to those 
of adults [195]. Interventional studies on small bowel endoscopy mostly reported on double-balloon 
enterosocopy using an endoscope with either 9.4 mm or 8.3 mm diameter [39,40,196].  
Angiodysplastic lesions, polyps, Meckel‟s diveritculi, chronic mucosal erosive/inflammatory diseases such 
as diaphragm disease and congenital lesions such as duplication cysts are all noted in the literature as 
causes of bleeding either acutely or in a more chronic fashion. Diagnostic approaches include VCE, double 
balloon enteroscopy, CT-scan, CT-angiogram, intra-vascular angiography and isotope labelled bleeding 
scans. 
 
ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATOGRAPHY (ERCP). 
ESGE/ESPGHAN suggest ERCP in pediatric patients (>1 year old) for therapeutic purposes following 
diagnostic information from non-invasive diagnostic modalities such as magnetic resonance cholangio-
pancreatography (MRCP). Diagnostic ERCP can be considered in selected cases where advanced non-
invasive imaging is inconclusive. 
 
ESGE/ESPGHAN recommend that therapeutic ERCP in pediatric patients (>1 year old) is considered 
for diseases listed in Table 6 following diagnostic information from non-invasive modalities such as 
magnetic resonance cholangio-pancreatography (MRCP). Results and complication rates of ERCP in 
children are similar to those reported in adults.  
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Published series on pediatric ERCP are retrospective data collections. Indications for ERCP in children are 
more frequently related to congenital abnormalities or trauma than to malignancy, which is more frequent 
in adults [197]. The division between biliary and pancreatic indications is age-dependent: pancreatic and 
biliary indications prevail in children of 7-12 years and 13-17 years, respectively while they are similarly 
distributed in children younger than 6 years [198]. Indications for ERCP in pediatric patients are 
summarized in Table 6. 
Currently, the majority of ERCPs in children are therapeutic as MRCP has mostly replaced diagnostic 
ERCP but this is not reflected in the literature. [199]. MRCP accurately depicts pancreatico-biliary anatomy 
and related diseases in children and secretin stimulation can enhance the visualization of non-dilated 
pancreatic ducts thereby improving diagnostic sensitivity [200]. Two large retrospective series in children 
with a mean age of 10 years [199,200] reported an 11-13% non-diagnostic rate of MRCP and in such cases 
diagnostic ERCP can be considered.  
Technical success for diagnostic and therapeutic ERCP in children (>1 year old) is high, with adverse event 
rates similar to those in adults [201,202]. The success rate reported in pediatric ERCP case series is > 90%, 
with a complication rate of 2.3-9.7%, and no procedure-related mortality [197,198,201-213]. A 
retrospective case-controlled study [201] compared results of ERCP in children and adults performed at the 
same center. Pediatric and adult patients were matched according to indications, diagnostic findings and 
technical complexity. ERCP success rate was 97.5% in children vs 98% in the adult cohort and 
complications rates were similar (3.4% in adults vs 2.5% in pediatric patients). The risk of post-ERCP 
pancreatitis is increased in therapeutic vs diagnostic ERCP, in the case of pancreatic duct injection and in 
more (vs less) complex procedures in children [202,211,214]. 
Chronic pancreatitis (CP) is a frequent indication for therapeutic ERCP in children. ESGE recommend 
endotherapy as a first-line therapy for CP in children starting at 8 years in the same conditions as in adults 
[215]. Two recently published large series [216,217] confirmed good results of endoscopic treatment of CP 
in children with complete pain resolution in 63.6% of the cases and improvement in 21.6% [216], while 
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pancreatic duct stenting significantly decreased the number of pancreatitis after a mean follow-up of 4.5 
year [217].   
 
ESGE/ESPGHAN suggest that diagnostic ERCP in neonates and infants (≤ 1 year old) with cholestatic 
hepatobiliary disease is considered if non-invasive investigations are not conclusive in order to allow 
timely referral to surgery for suspected biliary atresia or to avoid unnecessary surgery if biliary atresia is 
excluded.   
The first-line imaging modalities in neonatal cholestasis are abdominal ultrasound (triangular cord sign) 
and cholescintigraphy; ERCP and MRCP are not routinely recommended for the diagnosis of cholestatic 
jaundice in infants [218]. 
In the setting of neonatal anatomy, and in particular, the minute structures of biliary hypoplasia or atresia 
(BA), MRCP still appears to have unsatisfactory diagnostic accuracy (70% in a recent series on 190 
infants) [219]. As the diagnosis of BA at MRCP is based on the absence of visualization of the extrahepatic 
bile ducts and a prospective evaluation [220] of normal infants by MRCP visualized extrahepatic bile ducts 
in 62.5% of the cases, the authors concluded that MRCP led to a high level of false positivity in the setting 
of neonatal cholestasis.  
In this particular indication, retrospective series [221-227] report that ERCP has a  greater than 85% 
success rate but also report a complication rate of up to 10%, although this  included cases of increased 
pancreatic enzymes. All complications resolved by conservative treatment. Procedure-related mortality was 
not reported. Keil et al [221], in a series of 104 infants, reported 86% sensitivity and 94% specificity of 
ERCP for BA and 100% sensitivity and 90% specificity for choledochal cyst. According to published data 
[221,222,224-227] ERCP avoided unnecessary laparotomies in 18-42% of the infants. Liver biopsy is 
indicated as a complimentary investigation especially if ERCP is inconclusive [218]. 
ERCP currently offers superior diagnostic visualization of the biliary tree in infants and neonates [221]. 
However ERCP remains an invasive procedure, thus its indication in infants needs to be carefully evaluated 
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in a multidisciplinary setting, balancing risks and benefits. 
 
ESGE/ESPGHAN recommend that ERCP in children is performed by an experienced endoscopist, in a 
high-volume tertiary care center and with pediatric involvement. 
 
The annual number of pediatric ERCPs performed even in a referral endoscopy unit is usually low. The two 
largest published series [206,210] report 24 and 36 pediatric ERCPs/year; in neonates and infants this 
figure is lower with a minimum of 2.7 ERCP/year and a maximum of 20 [224]. Most pediatric endoscopy 
training programs offer limited exposure of their trainees to ERCP. Training in ERCP requires performance 
numbers that often exceed the number of patients an average pediatric gastroenterologist will encounter in 
their training. Pediatric gastroenterologists undoubtedly perform a lower volume of ERCP compared with 
adult-trained endoscopists at expert centers and it could be argued that initial numbers for competency 
should be the same [228,229].  North American Society for Pediatric Gastroenterology, Hepatology and 
Nutrition [230] suggests a minimum of 200 diagnostic and therapeutic ERCPs to achieve competence in 
pediatric patients, although this is a suggestion rather than based on evaluation of prospective competence. 
The combination of a pediatric gastroenterologist, who is knowledgeable about the pediatric GI disease, 
with an experienced ERCP endoscopist is perhaps an ideal alternative. 
 
ESGE/ESPGHAN suggest GA for ERCP in children. Deep/conscious sedation can be considered for 
teenagers (age 12-17 years) although GA is the preferred choice. 
 
Given the long duration and degree of difficulty of ERCP in small children and neonates, as well as the 
softness of their tracheal wall, it is recommended to perform ERCP in children under GA with endotracheal 
intubation. Some series report the use of conscious/deep sedation in 70% of cases but this should be 
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considered to be historical and age-dependent and should not be considered for children under 12 years of 
age [207,208,211].  
 
Prophylaxis of post-ERCP pancreatitis with NSAID (diclofenac/indomethacin suppository) is 
recommended in children older than 14 years. 
 
No RCTs on the prophylaxis of post-ERCP pancreatitis (PEP) in children have been published. In a series 
of 423 ERCPs, prophylactic pancreatic stenting was associated with higher rates of post-ERCP pancreatitis 
in high-risk patients and did not eliminate severe PEP [214]. Pharmacologic prophylaxis with 
diclofenac/indomethacin suppositories are recommended in adults [231] and may be used in children 
although evidence is lacking to date. 
 
Protection of radiosensitive organs (thyroid gland, breasts, gonads and eyes) is recommended together 
with adjustment of collimation to the smaller size of children. 
 
Children are more sensitive than adults to radiation exposure and the life-time risk of cancer induction is 
possibly 3-5 times higher. ESGE guidelines on radiation exposure [232] recommends to adjust collimation 
to the smaller size of the patient and to protect with radiation protection shields the most radiosensitive 
organs (thyroid gland, breasts, gonads, and eyes) and to keep these organs outwith the main X-ray beam. 
 
ESGE/ESPGHAN recommend the pediatric 7.5 mm duodenoscope for children weighing <10 kg and 
that a therapeutic duodenoscope can be used in those weighing ≥10 kg.  
 
ERCP in infants and neonates (≤ 1 year old) is feasible with a 7.5 mm pediatric duodenoscope. This 
endoscope has a 2 mm working channel limiting the array of devices that can be used, however double-
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lumen sphincterotomes, extraction baskets, and retrieval balloons are commercially available. Previously 
specific pediatric ERCP scopes with a standard 3.2 mm working channel or a therapeutic 4.2 mm working 
channels were available but are no longer commercially available. Commercially available therapeutic 
duodenoscopes have an insertion tube diameter of 11.3-11.6 mm and a distal end of 13-13.5 mm. (Table 4) 
 
ENDOSCOPIC  ULTRASONOGRAPHY (EUS). 
The endobronchial ultrasound (EBUS) can be adapted for EUS in children with a weight below 15 kg. A 
standard linear echoendoscope should only be employed in children under general anesthesia,  
considering the stiff and potentially traumatic distal part.  
 
ESGE-ESPGHAN suggest the use of EUS in children only in tertiary referral centers with experience in 
therapeutic endoscopy. Strict collaboration between adult and pediatric gastroenterologists is required in 
the case of EUS with standard echoendoscopes. 
 
Experience of EUS in pediatric patients is limited partly because commercially available echoendoscopes 
have a distal end diameter of 11-14 mm for radial probes and 14 mm for linear probes which cannot 
traverse from D1 to D2 small children. GA and careful insertion of the rigid tip of the linear echoendoscope 
is needed. The use of adult echoendoscopes was recently described [233] in children aged >3 years with 
weight ≥15 Kg. In smaller children the Endobronchial Ultrasound (EBUS) endoscope can be considered 
(Table 4). 
Reported experiences with standard EUS scopes and mini-probes in children are limited to small series 
[233] [234-251], with only 2 papers including more than 50 cases [233,243]. Many papers are from adult 
endoscopy centers, which routinely perform EUS with standard echoendoscopes.   
Mini-probes can be used with standard endoscopes in small children [234-240] and allow EUS in special 
anatomic situations such as stenoses through which standard EUS scopes may not feasibly be passed. 
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ESGE-ESPGHAN suggest the use of radial EUS with mini-probes to diagnose congenital esophageal 
strictures (tracheobronchial remnants vs fibromuscular stenosis subtypes). 
 
Congenital esophageal stenosis (CES) is an esophageal malformation with a stenosis generally located in 
the middle or more often in the lower esophagus. Three CES subtypes have been described: fibromuscular, 
tracheal cartilaginous remnants and the membranous web. In about 10% CES is associated with esophageal 
atresia [247] and differentiation between the CES subtypes is possible by histopathology after surgical 
resection [234,235,239,240,247]. 
A systematic review [247] from 144 CES cases confirmed the importance of EUS as the main diagnostic 
tool to distinguish CES subtypes and modify patient management. In tracheal cartilaginous remnant CES, 
some authors suggest stenosis resection and anastomosis to avoid the risk of post-dilation esophageal 
perforation [235,247]. A recent series reported CES dilations effective in all the different CES subtypes in 
96% of the cases and suggests that surgery is reserved for cases of endoscopic dilation failure [252]. 
 
ESGE/ESPGHAN suggest consideration of EUS for the diagnosis of pancreatico-biliary diseases in 
children where non-invasive imaging modalities (ultrasonography, MRCP) are inconclusive (Table 7). 
 
ESGE/ESPGHAN suggest EUS-guided drainage of pancreatic pseudocysts in children should be 
performed in in large EUS centers with specific experience and expertise. 
 
EUS and EUS-guided fine-needle aspiration (FNA) have been reported as feasible in small series of 
children for assessing pancreatico-biliary diseases [233,241-246] where non-invasive imaging modalities 
(e.g. MRCP) are inconclusive. Therapeutic EUS with the drainage of pancreatic pseudocysts can be 
Copyright © ESPGHAN and NASPGHAN. All rights reserved.
performed with the same technique as that described in adult patients although in large cysts EUS guidance 
may not be necessary [233,250,251]. 
Indications for EUS in children are summarized in Table 7. 
  
ESGE and ESPGHAN guidelines represent a consensus of best practice based on the available evidence at 
the time of preparation. They may not apply in all situations and should be interpreted in the light of 
specific clinical situations and resource availability. Further controlled clinical studies may be needed to 
clarify aspects of these statements, and revision may be necessary as new data appear. Clinical 
considerations may justify a course of action at variance to these recommendations. ESGE and ESPGHAN 
guidelines are intended to be an educational device to provide information that may assist endoscopists in 
providing care to patients. They are not rules and should not be construed as establishing a legal standard of 
care or as encouraging, advocating, requiring, or discouraging any particular treatment. 
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 Table 1. Typical diagnostic and therapeutic indications, non-indications and contraindications for 
esophagogastroduodenoscopy (EGD) in pediatric patients. 
Diagnostic indications Therapeutic indications Non-indications Contraindications 
Weight loss, failure to 
thrive 
Percutaneous endoscopic 
gastrostomy (re)placement  
Uncomplicated 
Gastroesophageal Reflux 
Disease (GERD) 
To diagnose perforation 
Unexplained anemia Duodenal tube placement  Functional Gastrointestinal 
(GI) disorders 
 
Abdominal pain with 
suspicion of an organic 
disease 
Foreign body removal  
Dysphagia or odynophagia Food impaction  
Caustic ingestion Hemostasis   
Recurrent vomiting with 
unknown cause 
Percutaneous jejunostomy 
placement 
 
Hematemesis Esophageal varices  
Hematochezia Dilatation of esophageal 
or upper GI strictures 
 
Unexplained chronic 
diarrhea 
Perforation closure if this 
occurs during an 
endoscopy itself 
 
Suspicion of graft versus 
host disease 
Achalasia pneumodilation 
or occasionally botulinum 
injection 
 
GI allergy PEGJ tube insertion  
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 Cysto-gastrostomy for 
drainage of pancreatic 
pseudocyst (preferably 
with endoultrasound 
guidance) 
 
Chronic GERD to exclude 
other diseases or 
surveillance of Barrett‟s  
esophagus 
Polypectomy, 
endomucosal resection  
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Table 2. Diagnostic indications for EGD in pediatric patients. Symptoms/signs according to 
suspected disease. 
 
Symptoms/Signs Suspicion of: 
Weight loss, failure to thrive, chronic diarrhea, 
malabsorption, anemia, abdominal pain with 
suspicion of an organic disease 
Celiac disease, IBD, giardia, allergic 
enteritis/enteropathy, bleeding lesions, graft versus 
host disease, peptic ulcer disease. 
Dysphagia, odynophagia, chest pain, feeding 
difficulty 
 
Foreign-body ingestion, food impaction, post-caustic 
ingestion, eosinophilic esophagitis, achalasia, 
aberrant vasculature affecting the esophagus, 
congenital webs or other abnormaities such as 
Schatzki‟s ring, stricture post-surgical e.g. post-
repair of tracheo-esophageal fistula 
 
 
 
Hematemesis, hematochezia, melena Polyps, angiodyspasia, arterio-venous 
malformations, peptic ulcer with or without H.pylori 
infection, less common conditions such as 
duplication cysts 
Family history of polyposis syndromes  Polyps (diagnostic and surveillance) 
Vomiting Any obstructive or partially obstructive pathology 
involving the upper GI tract e.g. pyloric stricturing, 
duodenal webs and strictures, bezoars, superior 
mesenteric artery syndrome etc; allergic GI 
pathology; peptic ulceration; assessment of 
esophagitis associated with reflux. 
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Table 3. Indication and site of tissue sampling during upper and lower endoscopy in pediatric 
patients. 
 
Indication ‘Tissue samples: sites and numbers’ 
Eosinophilic esophagitis At least 3 biopsy sites should be targetted with 1-2 biopsies 
from proximal, middle and distal esophagus, regardless of 
the endoscopic appearance of the esophagus  
Helicobacter pylori infection 2 biopsies from both the antrum and the corpus (±fundus) 
Celiac disease At least 1 biopsy from the duodenal bulb and at least 4 
biopsies from the second or third portion of the duodenum  
IBD  Multiple biopsies (2 or more per section) from all sections 
of the visualized GI tract, even in the absence of 
macroscopic lesions 
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Table 4. Type/size of  GI endoscope in pediatric patients according to body weight. 
 
Weight or age EGD Colonoscopy ERCP EUS 
< 10 kg or  < 1 year 
≤ 6 mm gastroscope preferred. 
Consider standard adult 
gastroscope if endotherapy 
required. 
≤ 6 mm gastroscope, 
standard adult gastroscope 
or pediatric colonoscope 
(<5-8kg or <6 months then 
an upper GI endoscope can 
be used and the size of the 
scope would depend on the 
size of the child – neonatal 
colonoscopy is rare but 
may require a paediatric 
upper GI endoscope). 
7.5 mm duodenoscope. Miniprobe or 
7.4 mm EBUS-scope. 
≥ 10 kg or ≥ 1 year 
Standard adult gastroscope. 
Therapeutic gastroscope if needed. 
Pediatric or adult 
colonoscope. 
Therapeutic 
duodenoscope. 
(4.2 mm operative 
channel) 
Miniprobe or 
7.4 mm EBUS-scope. 
≥ 15 kg or ≥ 3 years - - - 
Adult radial / linear 
Echoendoscope 
 
 
EGD, esogastroduodenoscopy;  
 
ERCP, endoscopic retrograde cholangiopancreatography;  
 
EUS, endoscopic ultrasonography;   
 
EBUS: Endobronchial Ultrasound. 
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Table 5. Typical diagnostic and therapeutic indications, non-indications and contraindications for 
ileo-colonoscopy in pediatric patients. 
 
Diagnostic indications Therapeutic indications Non- 
indications 
Contraindications 
Unexplained anemia  Polypectomy, endomucosal 
resection or extended 
submucosal dissection and 
removal of sessile polyps 
Functional GI 
disorders  
Toxic megacolon 
Constipation with 
normal fecal 
calprotectin 
Unexplained chronic diarrhea Dilatation of ileo-colonic 
or colonic stenosis 
 Recent colonic 
perforation 
Peri-anal lesions (fistula, abscess) Treatment of bleeding 
lesions 
 Recent intestinal 
resection 
 (< 7days) 
Rectal blood loss Foreign body removal  
Unexplained failure to thrive  Reduction of sigmoidal 
volvulus 
 
  
Initial work up for IBD Cecostomy or 
sigmoidostomy 
 
Suspicion of graft versus host disease  
Rejection or complications after 
intestinal transplantation 
 
Radiological suspicion of ileo-colonic 
stenosis/stricture 
 
Polyposis syndromes  
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Orofacial granulomatosis when 
Crohn‟s disease is suspected 
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Table 6. Typical ERCP indications in pediatric patients. 
 
Biliary Pancreatic 
Diagnostic Therapeutic Diagnostic Therapeutic 
Cholestasis  
in neonates and infants  
Common bile duct stones  
Evaluation of 
anomalous  
pancreatico-biliary 
junction  
Chronic pancreatitis 
Choledochal cyst 
Bile leak  
(post-surgical/ 
post-traumatic) 
 
Recurrent acute pancreatitis 
Primary sclerosing 
cholangitis  
(brush cytology) 
Benign biliary strictures 
 
Pancreas divisum 
 
Primary sclerosing 
cholangitis   
Pancreatic duct leak  
(post-surgical/ 
post-traumatic) 
 
Malignant biliary strictures 
 
Pancreatic pseudocyst 
 
Parasitosis  
(Ascariasis, Fasciola) 
 
Injection of botulinum toxin 
for sphincter of Oddi 
dysfunction 
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Table 7. Typical  EUS indications in pediatric patients. 
Esophagus Stomach Duodenum Pancreatico-biliary 
Congenital esophageal 
stenosis 
Gastric duplication Duodenal duplication Bile duct stone 
Eosinophilic esophagitis Gastric varices 
 
Pancreatic pseudocyst 
(diagnosis and treatment) 
Esophageal duplication 
  
Pancreatic disease (± FNA) 
 
FNA: Fine-needle aspiration. 
 
 
 
 
